MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tcm.2026.01.002

Медицинская библиотека · Trends in cardiovascular medicine · 2026

Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases.

Imazio Massimo, Collini Valentino, Merlo Marco, Aimo Alberto, Autore Camillo, Barison Andrea, Bauce Barbara, Biagini Elena, Cappelli Francesco, Castelletti Silvia, D'Ascenzi Flavio, De Gregorio Cesare, Marzo Francesca, Musumeci Beatrice, Pedrinelli Roberto, Paolillo Stefania, Perrone-Filardi Pasquale, Limongelli Giuseppe, Sinagra Gianfranco

СтатьяОбзорПеревод в очереди

Аннотация

The 2025 European Society of Cardiology (ESC) guidelines and the 2024-2025 American College of Cardiology (ACC) consensus documents redefine the management of myocarditis and pericarditis, with notable convergence, yet key differences. Both emphasize early, accurate diagnosis, particularly through cardiac magnetic resonance (CMR), which now often supersedes immediate biopsy in stable, uncomplicated cases of acute myocarditis. The ESC introduces a unified "inflammatory myopericardial syndrome" (IMPS) framework encompassing myocarditis, pericarditis, and overlap syndromes, while the ACC provides separate pathways, including a novel four-stage clinical classification of myocarditis. Therapeutically, both endorse non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine for pericarditis and myopericarditis, and heart failure-directed therapy for myocarditis, while reserving immunosuppression for select cases. Importantly, interleukin-1 (IL-1) blockade has emerged as a pivotal therapy in recurrent pericarditis, receiving a Class I recommendation in ESC guidelines and strong endorsement in ACC guidance. Prognostic assessment focuses on identifying high-risk features and structured follow-up with imaging and biomarkers. Divergences in terminology, staging, and diagnostic thresholds underscore opportunities for further harmonization. The ESC and ACC documents align in a patient-tailored, evidence-informed approach to management.

Для цитирования: Imazio Massimo, Collini Valentino, Merlo Marco, Aimo Alberto, Autore Camillo, Barison Andrea, Bauce Barbara, Biagini Elena, Cappelli Francesco, Castelletti Silvia, D'Ascenzi Flavio, De Gregorio Cesare, Marzo Francesca, Musumeci Beatrice, Pedrinelli Roberto, Paolillo Stefania, Perrone-Filardi Pasquale, Limongelli Giuseppe, Sinagra Gianfranco. Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases.. Trends in cardiovascular medicine. 2026. DOI: 10.1016/j.tcm.2026.01.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.